Nucleic Acid Amplification Testing Market Size Projected To Reach $19.26 Billion By 2034 With A Cagr Of 15%

"The Nucleic Acid Amplification Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Projected Growth of the Nucleic Acid Amplification Testing Market?
The nucleic acid amplification testing market size will grow from $9.56 billion in 2024 to $11.03 billion in 2025 at a compound annual growth rate (CAGR) of 15.3%. The growth in the historic period is attributed to rising awareness of infectious disease diagnosis, emergence of new pathogens, shift toward personalized medicine, demand for point-of-care testing, and regulatory approvals and guidelines.

The nucleic acid amplification testing market size is expected to reach $19.26 billion by 2029, at a CAGR of 15.0%. Growth is attributed to the increasing incidence of infectious diseases, need for large-scale testing, investments, demand for rapid testing methods, and advanced diagnostics. Key trends include AI integration, wearable/implantable devices, point-of-car

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19619

What Are the Different Nucleic Acid Amplification Testing Market Segments?
The nucleic acid amplification testingmarket covered in this report is segmented -

1) By Type: Target Amplification Systems, Probe Amplification Systems, Signal Amplification Systems
2) By Product Type: Consumables, Instruments Or Systems
3) By Technology: Polymerase Chain Reaction (PCR) Tests, Isothermal Nucleic Acid Amplification Technology (INAAT) Tests, Ligase Chain Reaction (LCR) Tests
4) By Application: Infectious Disease Testing, Oncology Testing, Genetic And Mitochondrial Disease Testing, Other Applications
5) By End-Use: Hospitals, Diagnostic Laboratories, Biotechnology Companies, Other End-Users

Subsegments:
1) By Target Amplification Systems: Polymerase Chain Reaction (PCR), Real-Time PCR (qPCR), Reverse Transcription PCR (RT-PCR), Nested PCR, Multiplex PCR, LAMP (Loop-Mediated Isothermal Amplification),
2) By Probe Amplification Systems: Nucleic Acid Sequence-Based Amplification (NASBA), Hybridization-Based Amplification, Branch Chain Amplification (BCA), Strand Displacement Amplification (SDA),
3) By Signal Amplification Systems: Enzyme-Linked Signal Amplification, Fluorescent Signal Amplification, Chemiluminescent Signal Amplification, Electrochemical Signal Amplification, Magnetic Particle-Based Signal Amplification

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19619&type=smp

What Are the Primary Drivers Shaping the Nucleic Acid Amplification Testing Market?
The growing prevalence of infectious diseases is anticipated to drive the expansion of the nucleic acid amplification testing market. Infectious diseases, caused by organisms that can spread through direct or indirect contact, are on the rise due to factors like antibiotic resistance, climate change, changes in human behavior, and agricultural practices. Nucleic acid amplification testing (NAAT) helps in quickly and accurately detecting infectious pathogens, facilitating prompt diagnosis and treatment to curb disease transmission. For example, in October 2023, the Public Health Agency of Canada reported 4,216 hospitalizations in the 2022-2023 season related to influenza. Thus, the rising incidence of infectious diseases is fueling market growth.

Which Companies Are Leading in the Nucleic Acid Amplification Testing Market?
Major companies operating in the nucleic acid amplification testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Siemens Healthineers, Becton, Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics, Agilent Technologies Inc., Grifols S.A., Hologic Inc., bioMerieux SA, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., Cepheid Inc., GenScript Biotech Corporation, ARUP Laboratories, BGI Group, Promega Corporation, Meridian Bioscience Inc., Takara Bio Inc., Eiken Chemical Co. Ltd., New England Biolabs Inc., TwistDx Limited, Bioneer Corporation

What Trends Are Expected to Dominate the Nucleic Acid Amplification Testing Market in the Next 5 Years?
Major Companies in the nucleic acid amplification testing market are developing innovative solutions like in vitro diagnostic (IVD) assays to screen donated blood for CMV using nucleic acid amplification technology (NAT) under the IVDR. IVD assays test biological samples to detect diseases in a laboratory setting. For instance, GFE, a Germany-based company, launched the PoET CMV in June 2024, an IVD assay designed for the rapid detection of cytomegalovirus (CMV) infections. This assay provides high sensitivity and specificity, enabling early diagnosis and monitoring of CMV, particularly in transplant patients and immunocompromised individuals.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/nucleic-acid-amplification-testing-global-market-report

What Are the Top Revenue-Generating Geographies in the Nucleic Acid Amplification Testing Market?
North America was the largest region in the nucleic acid amplification testing (NAAT) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nucleic acid amplification testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Nucleic Acid Amplification Testing Market?
2. What is the CAGR expected in the Nucleic Acid Amplification Testing Market?
3. What Are the Key Innovations Transforming the Nucleic Acid Amplification Testing Industry?
4. Which Region Is Leading the Nucleic Acid Amplification Testing Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments."

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.